Avricore Financial Statements From 2010 to 2024
| AVCRF Stock | USD 0.06 0.01 17.47% |
Check Avricore Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avricore Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . Avricore financial statements analysis is a perfect complement when working with Avricore Health Valuation or Volatility modules.
Avricore |
Avricore Health Company Current Valuation Analysis
Avricore Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Avricore Health Current Valuation | 21.9 M |
Most of Avricore Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avricore Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Avricore Health has a Current Valuation of 21.9 M. This is 99.85% lower than that of the Healthcare sector and 99.72% lower than that of the Diagnostics & Research industry. The current valuation for all United States stocks is 99.87% higher than that of the company.
Avricore Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Avricore Health's current stock value. Our valuation model uses many indicators to compare Avricore Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avricore Health competition to find correlations between indicators driving Avricore Health's intrinsic value. More Info.Avricore Health is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avricore Health's earnings, one of the primary drivers of an investment's value.About Avricore Health Financial Statements
Avricore Health stakeholders use historical fundamental indicators, such as Avricore Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Avricore Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Avricore Health's assets and liabilities are reflected in the revenues and expenses on Avricore Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Avricore Health. Please read more on our technical analysis and fundamental analysis pages.
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada. Avricore Health is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Avricore Pink Sheet
Avricore Health financial ratios help investors to determine whether Avricore Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avricore with respect to the benefits of owning Avricore Health security.